Common metabolic drug helps memory in mice

Share this article:
A drug that has until now been prescribed to treat patients with a certain metabolic disorder has been found to improve the memory of laboratory animals with Alzheimer's disease, according to a recent report.

Sodium phenylbutyrate is commonly used to treat patients who experience an alteration in the urea cycle. Researchers discovered that the drug also helped certain proteins, which are responsible for neuron connections, fuse together, resulting in improved learning capacity of lab mice. Researchers at the Center for Applied Medical Research (CIMA) at the University of Navarra are investigating which element of the drug is responsible for the beneficial effects.

Because sodium phenylbutyrate is already available for use, researchers suggest it could potentially be used to treat Alzheimer's and other dementia patients much sooner than other experimental drugs. The report was published in the journal Neuropsychopharmacology.
Share this article:

More in News

Facilities on high alert for Ebola in Ohio; authorities issue guidance

Facilities on high alert for Ebola in Ohio; ...

Federal and state organizations have released new Ebola guidance for healthcare workers in long-term care and other settings, following the second case of a nurse acquiring the virus in the ...

Nonprofit senior living margins increased by 50%, survey finds

Average operating margins increased dramatically in the last year for nonprofit senior living companies, according to a recent survey of C-suite executives.

Nursing home psychiatrist in federal custody on 52 counts of fraud, including ...

Authorities have arrested a nursing home psychiatrist and charged him with 52 counts of healthcare fraud, the U.S. Attorney for the Northern District of Texas announced Thursday.